Profile data is unavailable for this security.
About the company
Amrutanjan Health Care Limited is an India-based company, which is engaged in the business of manufacturing, supplying and sale of products in pain management, congestion management, beverages, and hygiene. Its segments include OTC Products, Beverages, and Others. The OTC Products segment is engaged in manufacturing products for pain management, congestion management and hygiene. The Beverages segment is engaged in manufacturing fruit juices and oral hydration drinks. The Others segment includes the pain management center. The Company’s pain management products include Pain Balm Extra Power, Strong Pain Balm, New Maha Strong Pain Balm, Roll on and Advanced Back Pain + Roll-On, among others. Its congestion management products include Relief Cold Rub, Relief Nasal Inhaler, Relief Cough Syrup and Relief Swas Mint. Its women's hygiene products include Comfy Snug Fit, Comfy Snug Fit XL and Comfy Snug Fit ULTRA XL. The Company’s beverages include Fruitnik and Fruitnik Electro+.
- Revenue in INR (TTM)3.94bn
- Net income in INR440.09m
- Incorporated1936
- Employees575.00
- LocationAmrutanjan Health Care LtdNEW NO.103, OLD NO. 42-45LUZ CHURCH ROADMYLAPORECHENNAI 600004IndiaIND
- Phone+91 4 424994465
- Fax+91 4 424994585
- Websitehttps://www.amrutanjan.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ngl Fine Chem Ltd | 3.17bn | 380.04m | 14.42bn | 343.00 | 37.95 | -- | 29.00 | 4.55 | 61.52 | 61.52 | 513.13 | -- | -- | -- | -- | 9,241,813.00 | -- | 15.74 | -- | 20.73 | 53.94 | 45.27 | 11.99 | 13.43 | -- | 34.92 | -- | 3.47 | -12.42 | 19.17 | -58.92 | 10.23 | 5.65 | -- |
| Hester Biosciences Ltd | 3.05bn | 188.89m | 15.12bn | 693.00 | 71.41 | 5.18 | 39.44 | 4.97 | 24.89 | 24.89 | 392.38 | 343.01 | 0.4572 | 1.20 | 3.85 | -- | 3.18 | 6.15 | 4.00 | 7.69 | 68.52 | 68.83 | 6.95 | 12.83 | 1.31 | 1.84 | 0.4466 | 23.27 | 14.45 | 11.33 | -29.06 | -14.59 | 1.49 | -11.42 |
| SMS Pharmaceuticals Ltd | 6.13bn | 360.58m | 17.50bn | 1.10k | 48.48 | -- | 24.19 | 2.85 | 4.26 | 4.26 | 72.40 | -- | -- | -- | -- | 5,597,176.00 | -- | 5.86 | -- | 7.77 | 31.67 | 33.18 | 6.65 | 8.34 | -- | 3.13 | -- | 6.26 | 0.4188 | 2.35 | -111.35 | -- | 28.46 | 3.71 |
| Themis Medicare Ltd | 3.82bn | 435.24m | 19.36bn | 996.00 | 44.56 | 5.13 | 34.72 | 5.07 | 4.72 | 4.72 | 41.41 | 41.03 | 0.7067 | 1.96 | 2.36 | -- | 8.06 | 11.12 | 11.07 | 16.46 | 64.19 | 61.49 | 11.40 | 14.96 | 1.44 | -- | 0.2023 | 8.28 | 7.74 | 15.75 | -23.51 | -- | 26.73 | -- |
| Amrutanjan Health Care Ltd | 3.94bn | 440.09m | 21.52bn | 575.00 | 49.24 | -- | 43.18 | 5.46 | 15.13 | 15.13 | 135.41 | -- | -- | -- | -- | 6,860,612.00 | -- | 17.04 | -- | 21.22 | 49.51 | 54.08 | 11.16 | 13.37 | -- | 341.76 | -- | 17.21 | -6.46 | 11.37 | -40.71 | 14.72 | 23.87 | 10.64 |
| Suven Life Sciences Ltd | 116.93m | -1.05bn | 21.83bn | 132.00 | -- | 8.08 | -- | 186.69 | -4.82 | -4.82 | 0.5359 | 12.38 | 0.0347 | -- | 11.17 | -- | -31.19 | -46.46 | -32.37 | -50.52 | -- | -- | -898.63 | -787.61 | 18.94 | -849.16 | 0.0026 | -- | -13.64 | -47.23 | 11.15 | -- | -- | -- |
| Solara Active Pharma Sciences Ltd | 14.07bn | -3.08bn | 23.36bn | 2.36k | -- | -- | -- | 1.66 | -78.92 | -78.92 | 360.06 | -- | -- | -- | -- | 5,958,916.00 | -- | 2.68 | -- | 4.10 | 40.47 | 44.49 | -21.88 | 4.58 | -- | -1.67 | -- | 10.10 | 13.83 | 22.61 | 61.86 | -- | 26.23 | -- |
| Morepen Laboratories Ltd | 16.31bn | 761.19m | 23.95bn | 1.65k | 31.04 | -- | 22.39 | 1.47 | 1.51 | 1.51 | 32.53 | -- | -- | -- | -- | 9,891,111.00 | -- | 7.39 | -- | 13.78 | 35.85 | 32.82 | 4.67 | 5.19 | -- | 27.34 | -- | 0.00 | -8.36 | 18.51 | -61.96 | 5.50 | 11.33 | -- |
| RPG Life Sciences Limited | 5.82bn | 876.60m | 25.05bn | 1.17k | 28.57 | 6.68 | 23.92 | 4.30 | 53.01 | 53.01 | 351.99 | 226.65 | 1.25 | 1.88 | 13.45 | -- | 18.81 | 16.07 | 25.10 | 21.77 | 68.30 | 64.04 | 15.06 | 11.99 | 1.50 | 246.84 | 0.00 | 29.27 | 13.50 | 12.01 | 29.60 | 51.98 | 28.60 | 46.14 |
| Innova Captab Ltd | -100.00bn | -100.00bn | 28.76bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 15.72 | -- | 6.26 | -- | -- | -- |
| SeQuent Scientific Ltd | 13.70bn | -358.69m | 28.94bn | 478.00 | -- | 4.42 | 90.65 | 2.11 | -1.45 | -1.45 | 56.27 | 26.32 | 0.8925 | 2.19 | 4.05 | -- | -1.93 | 1.09 | -3.27 | 1.76 | 44.53 | 42.74 | -2.16 | 1.18 | 0.7602 | 0.1376 | 0.4062 | -- | -3.60 | 5.68 | 70.40 | -- | 6.96 | -- |
| Jeena Sikho Lifecare Ltd | -100.00bn | -100.00bn | 29.46bn | 1.23k | -- | 93.17 | -- | -- | -- | -- | -- | 12.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.8228 | -- | 0.2681 | -- | 43.84 | -- | 77.37 | -- | -- | -- |
| Indoco Remedies Ltd | 18.17bn | 984.70m | 29.53bn | 6.10k | 30.45 | 2.66 | 15.63 | 1.62 | 10.52 | 10.52 | 193.15 | 120.38 | 0.9557 | 1.65 | 4.80 | -- | 5.10 | 6.88 | 7.02 | 9.85 | 69.23 | 66.66 | 5.34 | 6.93 | 0.9825 | 4.01 | 0.377 | 12.67 | 8.91 | 13.41 | -30.78 | -- | 34.54 | 37.97 |
| Supriya Lifescience Ltd | 5.54bn | 1.20bn | 30.31bn | 392.00 | 25.16 | -- | 22.40 | 5.47 | 14.97 | 14.97 | 68.93 | -- | -- | -- | -- | 14,144,410.00 | -- | 20.77 | -- | 29.06 | 61.94 | 55.83 | 21.72 | 24.33 | -- | 63.63 | -- | 2.02 | -13.04 | 16.70 | -40.81 | 59.41 | 85.55 | -- |
Data as of May 18 2024. Currency figures normalised to Amrutanjan Health Care Ltd's reporting currency: Indian Rupee INR
7.33%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| DSP Asset Managers Pvt. Ltd.as of 30 Apr 2024 | 1.47m | 5.02% |
| Sundaram Asset Management Co. Ltd.as of 30 Apr 2024 | 484.54k | 1.66% |
| Dimensional Fund Advisors LPas of 09 May 2024 | 88.99k | 0.30% |
| Alquity Investment Management Ltd.as of 30 Apr 2024 | 85.20k | 0.29% |
| SSgA Funds Management, Inc.as of 09 May 2024 | 11.91k | 0.04% |
| American Century Investment Management, Inc.as of 09 May 2024 | 2.92k | 0.01% |
| Dimensional Fund Advisors Ltd.as of 29 Feb 2024 | 892.00 | 0.00% |
| DFA Australia Ltd.as of 31 Dec 2023 | 509.00 | 0.00% |
| Matthews International Capital Management LLCas of 30 Sep 2021 | 0.00 | 0.00% |
More ▼
Data from 31 Mar 2024 - 16 May 2024Source: FactSet Research Systems Inc.
